Literature DB >> 22968412

Influence of Bacillus subtilis C-3102 on microbiota in a dynamic in vitro model of the gastrointestinal tract simulating human conditions.

M Hatanaka1, Y Nakamura, A J H Maathuis, K Venema, I Murota, N Yamamoto.   

Abstract

Survival and germination rate of Bacillus subtilis C-3102 spores were investigated in a stomach and small intestine model (TIM-1), while the impact of C-3102 cells that had passed through TIM-1 on human colon microbiota was evaluated in a model of the large intestine (TIM-2). The survival of C-3102 spores in TIM-1 was 99%; 8% of the spores had germinated. Effluent of TIM-1 was subsequently introduced into TIM-2 and a micro-array platform was employed to assess changes in the microbiota composition. The effluent, which contained germinated C-3102 cells, increased some Bifidobacterium species and decreased some Clostridium groups. These changes were greater compared to those obtained by adding C-3102 spores directly to TIM-2. The present study suggests that oral doses of B. subtilis C-3102 spores have the potential to modulate the human colon microbiota. This effect may be caused by germination of the spores in the gastrointestinal tract.

Entities:  

Mesh:

Year:  2012        PMID: 22968412     DOI: 10.3920/BM2012.0016

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  6 in total

Review 1.  Importance of the gastrointestinal life cycle of Bacillus for probiotic functionality.

Authors:  M Bernardeau; M J Lehtinen; S D Forssten; P Nurminen
Journal:  J Food Sci Technol       Date:  2017-05-23       Impact factor: 2.701

2.  Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota.

Authors:  Jonathan Thévenot; Lucie Etienne-Mesmin; Sylvain Denis; Sandrine Chalancon; Monique Alric; Valérie Livrelli; Stéphanie Blanquet-Diot
Journal:  Appl Environ Microbiol       Date:  2012-11-30       Impact factor: 4.792

3.  In vitro digestion of starches in a dynamic gastrointestinal model: an innovative study to optimize dietary management of patients with hepatic glycogen storage diseases.

Authors:  Tatiéle Nalin; Koen Venema; David A Weinstein; Carolina F M de Souza; Ingrid D S Perry; Mario T R van Wandelen; Margreet van Rijn; G Peter A Smit; Ida V D Schwartz; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2014-09-16       Impact factor: 4.982

4.  Probiotic survival during a multi-layered tablet development as tested in a dynamic, computer-controlled in vitro model of the stomach and small intestine (TIM-1).

Authors:  K Venema; J Verhoeven; S Verbruggen; L Espinosa; S Courau
Journal:  Lett Appl Microbiol       Date:  2019-10-09       Impact factor: 2.858

5.  Effect of Bacillus subtilis C-3102 on bone mineral density in healthy postmenopausal Japanese women: a randomized, placebo-controlled, double-blind clinical trial.

Authors:  Takuou Takimoto; Misaki Hatanaka; Tomohiro Hoshino; Tsuyoshi Takara; Ko Tanaka; Atsushi Shimizu; Hiroto Morita; Teppei Nakamura
Journal:  Biosci Microbiota Food Health       Date:  2018-06-16

6.  The Use of Ascophyllum nodosum and Bacillus subtilis C-3102 in the Management of Canine Chronic Inflammatory Enteropathy: A Pilot Study.

Authors:  Marco Isidori; Fabrizio Rueca; Francesca Romana Massacci; Manuela Diaferia; Andrea Giontella; Marco Caldin; Tommaso Furlanello; Ronald J Corbee; Gabriele Mannucci; Giovanni Pezzotti; Massimo Trabalza-Marinucci
Journal:  Animals (Basel)       Date:  2021-11-30       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.